Cargando…

Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome

A large number of adults and children consume soy in various forms, but little information is available regarding potential neurological side effects. Prior work indicates an association between the consumption of soy-based diets and seizure prevalence in mouse models of neurological disease and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westmark, Cara J., Kniss, Chad, Sampene, Emmanuel, Wang, Angel, Milunovich, Amie, Elver, Kelly, Hessl, David, Talboy, Amy, Picker, Jonathon, Haas-Givler, Barbara, Esler, Amy, Gropman, Andrea L., Uy, Ryan, Erickson, Craig, Velinov, Milen, Tartaglia, Nicole, Berry-Kravis, Elizabeth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602206/ https://www.ncbi.nlm.nih.gov/pubmed/33066511 http://dx.doi.org/10.3390/nu12103136

Ejemplares similares

Best Practices in Fragile X Syndrome Treatment Development
por: Erickson, Craig A., et al.
Publicado: (2018)

Soy Infant Formula may be Associated with Autistic Behaviors
por: Westmark, Cara J.
Publicado: (2013)

Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities
por: Weber, Jayne Dixon, et al.
Publicado: (2019)

Descriptive analysis of seizures and comorbidities associated with fragile X syndrome
por: Albizua, Igor, et al.
Publicado: (2022)

Soy Infant Formula and Seizures in Children with Autism: A Retrospective Study
por: Westmark, Cara J.
Publicado: (2014)

Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons
por: Westmark, Cara J.
Publicado: (2017)

A Hypothesis Regarding the Molecular Mechanism Underlying Dietary Soy-Induced Effects on Seizure Propensity
por: Westmark, Cara Jean
Publicado: (2014)

Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome
por: Farzin, Faraz, et al.
Publicado: (2011)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Effects of Soy-Based Infant Formula on Obesity and Neurodevelopment in an Autism Mouse Model
por: Westmark, Cara, et al.
Publicado: (2022)

Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome
por: Reisinger, Debra L., et al.
Publicado: (2020)

Consumption of Breast Milk Is Associated with Decreased Prevalence of Autism in Fragile X Syndrome
por: Westmark, Cara J.
Publicado: (2021)

Commentary: Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis
por: Westmark, Cara J.
Publicado: (2017)

Parental Reports on Early Autism Behaviors in Their Children with Fragile X Syndrome as a Function of Infant Feeding
por: Westmark, Cara J.
Publicado: (2021)

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
por: Luu, Skylar, et al.
Publicado: (2020)

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
por: Budimirovic, Dejan B., et al.
Publicado: (2017)

Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment
por: Hoffmann, Anne, et al.
Publicado: (2020)

Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model
por: Westmark, Cara J., et al.
Publicado: (2022)

Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction
por: Westmark, Cara J., et al.
Publicado: (2020)

Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives
por: Lozano, Reymundo, et al.
Publicado: (2022)

Executive Function in Fragile X Syndrome: A Systematic Review
por: Schmitt, Lauren M., et al.
Publicado: (2019)

Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
por: Knox, Andrew, et al.
Publicado: (2012)

Genomic Copy Number Variations in the Autism Clinic—Work in Progress
por: Velinov, Milen
Publicado: (2019)

APP Causes Hyperexcitability in Fragile X Mice
por: Westmark, Cara J., et al.
Publicado: (2016)

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice
por: Westmark, Cara J., et al.
Publicado: (2011)

Ketogenic Diet Affects Sleep Architecture in C57BL/6J Wild Type and Fragile X Mice
por: Westmark, Pamela R., et al.
Publicado: (2023)

Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome
por: Hessl, David, et al.
Publicado: (2019)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome
por: Coffman, Marika C., et al.
Publicado: (2020)

Novel Roles of Amyloid-Beta Protein Precursor Metabolites in Fragile X Syndrome and Autism
por: Westmark, Cara J., et al.
Publicado: (2016)

7q21.3 Deletion involving enhancer sequences within the gene DYNC1I1 presents with intellectual disability and split hand-split foot malformation with decreased penetrance
por: Delgado, Sara, et al.
Publicado: (2015)

FMR1 and Autism, an Intriguing Connection Revisited
por: Fyke, William, et al.
Publicado: (2021)

DOCK3-Associated Neurodevelopmental Disorder—Clinical Features and Molecular Basis
por: Alexander, Matthew S., et al.
Publicado: (2023)

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
por: Berry-Kravis, E, et al.
Publicado: (2009)

Targeted treatments for fragile X syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2011)

Efficient Delivery of FMR1 across the Blood Brain Barrier Using AAVphp Construct in Adult FMR1 KO Mice Suggests the Feasibility of Gene Therapy for Fragile X Syndrome
por: Chadman, Kathryn K., et al.
Publicado: (2023)

Developing BACE-1 inhibitors for FXS
por: Westmark, Cara J., et al.
Publicado: (2013)

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2022)

Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization
por: Cordeiro, Lisa, et al.
Publicado: (2010)

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a6c7tkou5uv7foenuatl2e5fgc